Device Week, 21 January 2021 – EY M&A Firepower, JPM and NANS events highlights, CorWave Profile
Citeline Podcasts - A podcast by Citeline
Categories:
In this week’s podcast, Medtech Insight's managing editor Marion Webb and deputy editor Reed Miller discuss highlights from the recent J.P. Morgan Healthcare and North American Neuromodulation Society (NANS) virtual meetings. London, UK-based reporter Barnaby Pickering profiles start-up CorWave SA, which developed a left ventricular assist device for treating end-stage heart failure. Listen to the podcast via the player below: NANS 2021: Nevro’s HF10 Spinal-Cord Stimulator Succeeds In Two Trials NANS 2021: Boston Scientific Advances New Personalized Pain Therapy JPM 2021: EY Says Pandemic Leaves Medtech With $500Bn In M&A Firepower Start-Up Spotlight: CorWave Takes Inspiration From Nature To Tackle Heart Failure JPM 2021: Conformis Announces ACS Knee For 2H 2021, Integra Weathers Pandemic JPM 2021: Intuitive Surgical, Accelerate Diagnostics, Siemens Healthineers, Exact Sciences, Renalytix JPM 2021: Boston Scientific, Abbott, Dexcom, Insulet, Silk Road Medical JPM 2021: Medtronic, Biogen, Edwards LifeSciences, Guardant Health, Illumina For more information on Medtech Insight and to start a free trial, click here: http://bit.ly/2w7LnlR Medtech Insight articles addressing topics discussed in this episode:
